Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	regulation of dendrite morphogenesis	RAP2A SGK1 TIAM1 FBXO31 HECW2 SIPA1L1	2.20e-05	103	113	6	GO:0048814
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	HIF1A USP17L4 USP17L2 USP17L1 RIPK2 ZMIZ1 DYSF TRIM5 FBXO31 HECW2 LTN1 HLTF USP17L3 UHRF1 HERC2 EPAS1 USP17L8	3.45e-05	1009	113	17	GO:0070647
Domain	HIF-1a_CTAD	HIF1A EPAS1	3.69e-05	2	114	2	PF08778
Domain	HIF-1_TAD_C	HIF1A EPAS1	3.69e-05	2	114	2	IPR014887
Domain	UCH	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.33e-05	71	114	5	PF00443
Domain	USP_2	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.33e-05	71	114	5	PS00973
Domain	USP_3	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.84e-05	72	114	5	PS50235
Domain	USP_dom	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.84e-05	72	114	5	IPR028889
Domain	Peptidase_C19_UCH	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.84e-05	72	114	5	IPR001394
Domain	HIF_alpha_subunit	HIF1A EPAS1	1.10e-04	3	114	2	IPR021537
Domain	HIF-1	HIF1A EPAS1	1.10e-04	3	114	2	PF11413
Domain	-	CUBN CDCP1 BMP1 CSMD1	2.84e-04	52	114	4	2.60.120.290
Domain	CUB	CUBN CDCP1 BMP1 CSMD1	3.06e-04	53	114	4	PS01180
Domain	CUB_dom	CUBN CDCP1 BMP1 CSMD1	4.05e-04	57	114	4	IPR000859
Domain	P-loop_NTPase	DNHD1 RAP2A MYH13 ABCA13 DDX60 DNAH2 KTI12 GAL3ST2 ORC4 HLTF MYO15A DDX24 AQR ADSS1	6.55e-04	848	114	14	IPR027417
Domain	USP_CS	USP17L2 USP17L1 USP17L3 USP17L8	7.09e-04	66	114	4	IPR018200
Domain	Znf_U1	ZNF385B ZNF385D ZMAT1	7.21e-04	29	114	3	IPR003604
Domain	ZnF_U1	ZNF385B ZNF385D ZMAT1	7.21e-04	29	114	3	SM00451
Domain	RPEL	MRTFB MRTFA	7.60e-04	7	114	2	PS51073
Domain	RPEL	MRTFB MRTFA	7.60e-04	7	114	2	SM00707
Domain	RPEL	MRTFB MRTFA	7.60e-04	7	114	2	PF02755
Domain	RPEL_repeat	MRTFB MRTFA	7.60e-04	7	114	2	IPR004018
Domain	USP_1	USP17L4 USP17L2 USP17L3 USP17L8	8.85e-04	70	114	4	PS00972
Pathway	REACTOME_RAS_PROCESSING	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	5.99e-06	45	82	5	MM15671
Pubmed	CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.	USP17L4 USP17L2 USP17L1 USP17L3 ATM USP17L8	3.33e-11	19	117	6	28067227
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	9.83e-11	10	117	5	24207026
Pubmed	DNA sequence and analysis of human chromosome 8.	USP17L4 USP17L1 RIPK2 EBF2 USP17L3 CSMD1 USP17L8	2.67e-10	48	117	7	16421571
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	3.07e-10	12	117	5	24695638
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.72e-10	14	117	5	11793228
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.70e-09	21	117	5	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.70e-09	21	117	5	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.70e-09	21	117	5	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.70e-09	21	117	5	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.70e-09	21	117	5	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.70e-09	21	117	5	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	9.94e-09	22	117	5	9154835
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.60e-08	24	117	5	8995226
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.99e-08	25	117	5	21115691
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	2.46e-08	26	117	5	35816173
Pubmed	ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis.	HIF1A ZMYND8 EPAS1	3.71e-08	3	117	3	29629903
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	4.40e-08	29	117	5	32527007
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	8.70e-08	33	117	5	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.02e-07	34	117	5	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.02e-07	34	117	5	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.02e-07	34	117	5	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.02e-07	34	117	5	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.02e-07	34	117	5	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.02e-07	34	117	5	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.02e-07	34	117	5	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.02e-07	34	117	5	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.02e-07	34	117	5	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.02e-07	34	117	5	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.02e-07	34	117	5	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.02e-07	34	117	5	21448158
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.18e-07	35	117	5	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.18e-07	35	117	5	21239494
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.37e-07	36	117	5	20147298
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.58e-07	37	117	5	20228808
Pubmed	Human and mouse proteases: a comparative genomic approach.	USP17L4 USP17L2 USP17L1 FREM1 USP17L3 USP17L8	3.36e-07	81	117	6	12838346
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.42e-07	50	117	5	31806660
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	LEMD3 RBMS1 ZMYND8 ORC4 MRTFB ATXN2 MACO1 SLC5A6 SIPA1L1 TLN1 LTN1 HLTF STIP1 LIMCH1 HERC2 EIF3I AQR	1.11e-05	1497	117	17	31527615
Pubmed	Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension.	HIF1A EPAS1	1.12e-05	2	117	2	31515405
Pubmed	Epigenetic regulation of HIF-1α in renal cancer cells involves HIF-1α/2α binding to a reverse hypoxia-response element.	HIF1A EPAS1	1.12e-05	2	117	2	21841824
Pubmed	A microfluidic oxygen gradient demonstrates differential activation of the hypoxia-regulated transcription factors HIF-1α and HIF-2α.	HIF1A EPAS1	1.12e-05	2	117	2	28840922
Pubmed	ECM-dependent HIF induction directs trophoblast stem cell fate via LIMK1-mediated cytoskeletal rearrangement.	HIF1A EPAS1	1.12e-05	2	117	2	23437279
Pubmed	Neuronal HIF-1α and HIF-2α deficiency improves neuronal survival and sensorimotor function in the early acute phase after ischemic stroke.	HIF1A EPAS1	1.12e-05	2	117	2	26746864
Pubmed	HIF-1α and HIF-2α correlate with migration and invasion in gastric cancer.	HIF1A EPAS1	1.12e-05	2	117	2	20559021
Pubmed	Loss of either hypoxia inducible factor 1 or 2 promotes lung cancer cell colonization.	HIF1A EPAS1	1.12e-05	2	117	2	21610325
Pubmed	Effect of radiation and ibuprofen on normoxic renal carcinoma cells overexpressing hypoxia-inducible factors by loss of von Hippel-Lindau tumor suppressor gene function.	HIF1A EPAS1	1.12e-05	2	117	2	15217953
Pubmed	Constitutive expression of HIF-α plays a major role in generation of clear-cell phenotype in human primary and metastatic renal carcinoma.	HIF1A EPAS1	1.12e-05	2	117	2	25046225
Pubmed	Hypoxia induced HIF-1/HIF-2 activity alters trophoblast transcriptional regulation and promotes invasion.	HIF1A EPAS1	1.12e-05	2	117	2	26531845
Pubmed	Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma.	HIF1A EPAS1	1.12e-05	2	117	2	20032376
Pubmed	The transition from HIF-1 to HIF-2 during prolonged hypoxia results from reactivation of PHDs and HIF1A mRNA instability.	HIF1A EPAS1	1.12e-05	2	117	2	36482296
Pubmed	Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patients.	CDCP1 EPAS1	1.12e-05	2	117	2	23378636
Pubmed	Low oxygen atmosphere facilitates proliferation and maintains undifferentiated state of umbilical cord mesenchymal stem cells in an hypoxia inducible factor-dependent manner.	HIF1A EPAS1	1.12e-05	2	117	2	24726658
Pubmed	Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.	HIF1A EPAS1	1.12e-05	2	117	2	17437013
Pubmed	DNA methylation repels binding of hypoxia-inducible transcription factors to maintain tumor immunotolerance.	HIF1A EPAS1	1.12e-05	2	117	2	32718321
Pubmed	Protein kinase C binding protein 1 inhibits hypoxia-inducible factor-1 in the heart.	HIF1A ZMYND8	1.12e-05	2	117	2	30395227
Pubmed	Hypoxia inducible factor: a potential prognostic biomarker in oral squamous cell carcinoma.	HIF1A EPAS1	1.12e-05	2	117	2	26880584
Pubmed	Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma.	HIF1A EPAS1	1.12e-05	2	117	2	15964822
Pubmed	Localization of immunoreactive HIF-1alpha and HIF-2alpha in neuroendocrine cells of both benign and malignant prostate glands.	HIF1A EPAS1	1.12e-05	2	117	2	17562539
Pubmed	[Expression of HIF-1alpha mRNA and HIF-2alpha mRNA in placentas of pregnant women with intrahepatic cholestasis of pregnancy].	HIF1A EPAS1	1.12e-05	2	117	2	17718430
Pubmed	Extensive regulation of the non-coding transcriptome by hypoxia: role of HIF in releasing paused RNApol2.	HIF1A EPAS1	1.12e-05	2	117	2	24363272
Pubmed	The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha.	HIF1A EPAS1	1.12e-05	2	117	2	17804822
Pubmed	Hypoxia and the expression of HIF-1alpha and HIF-2alpha in the retina of streptozotocin-injected mice and rats.	HIF1A EPAS1	1.12e-05	2	117	2	20005221
Pubmed	Inherent DNA-binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin.	HIF1A EPAS1	1.12e-05	2	117	2	30429208
Pubmed	HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism.	HIF1A EPAS1	1.12e-05	2	117	2	29176561
Pubmed	Regulation of the HIF pathway: enzymatic hydroxylation of a conserved prolyl residue in hypoxia-inducible factor alpha subunits governs capture by the pVHL E3 ubiquitin ligase complex.	HIF1A EPAS1	1.12e-05	2	117	2	12123724
Pubmed	Endothelial HIF-2α as a Key Endogenous Mediator Preventing Emphysema.	HIF1A EPAS1	1.12e-05	2	117	2	32515984
Pubmed	Increased size of solid organs in patients with Chuvash polycythemia and in mice with altered expression of HIF-1alpha and HIF-2alpha.	HIF1A EPAS1	1.12e-05	2	117	2	20140661
Pubmed	Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis.	HIF1A EPAS1	1.12e-05	2	117	2	12823854
Pubmed	The acquired radioresistance in HeLa cells under conditions mimicking hypoxia was attenuated by a decreased expression of HIF subunit genes induced by RNA interference.	HIF1A EPAS1	1.12e-05	2	117	2	25805230
Pubmed	Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids.	HIF1A EPAS1	1.12e-05	2	117	2	20513003
Pubmed	Differential regulation of HIF-mediated pathways increases mitochondrial metabolism and ATP production in hypoxic osteoclasts.	HIF1A EPAS1	1.12e-05	2	117	2	23303559
Pubmed	Endothelial deletion of hypoxia-inducible factor-2alpha (HIF-2alpha) alters vascular function and tumor angiogenesis.	HIF1A EPAS1	1.12e-05	2	117	2	19439736
Pubmed	HIF-1α and HIF-2α induced angiogenesis in gastrointestinal vascular malformation and reversed by thalidomide.	HIF1A EPAS1	1.12e-05	2	117	2	27249651
Pubmed	Myocardin related transcription factors are required for coordinated cell cycle progression.	MRTFB MRTFA	1.12e-05	2	117	2	23656782
Pubmed	Differential Contribution of N- and C-Terminal Regions of HIF1α and HIF2α to Their Target Gene Selectivity.	HIF1A EPAS1	1.12e-05	2	117	2	33321829
Pubmed	Differential expression of hypoxia-inducible factors related to the invasiveness of epithelial ovarian cancer.	HIF1A EPAS1	1.12e-05	2	117	2	34824343
Pubmed	Hypoxia Inducible Factors Modify Collagen I Fibers in MDA-MB-231 Triple Negative Breast Cancer Xenografts.	HIF1A EPAS1	1.12e-05	2	117	2	29247885
Pubmed	Oxygen-dependent changes in binding partners and post-translational modifications regulate the abundance and activity of HIF-1α/2α.	HIF1A EPAS1	1.12e-05	2	117	2	34285132
Pubmed	The hypoxia-inducible factors HIF1α and HIF2α are dispensable for embryonic muscle development but essential for postnatal muscle regeneration.	HIF1A EPAS1	1.12e-05	2	117	2	28232488
Pubmed	MRTF-A/B suppress the oncogenic properties of v-ras- and v-src-mediated transformants.	MRTFB MRTFA	1.12e-05	2	117	2	20338973
Pubmed	Hypoxia inducible factor promotes murine allergic airway inflammation and is increased in asthma and rhinitis.	HIF1A EPAS1	1.12e-05	2	117	2	21517900
Pubmed	Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene-induced senescence.	MRTFB MRTFA	1.12e-05	2	117	2	23853104
Pubmed	The Kaposi's Sarcoma-Associated Herpesvirus ORF34 Protein Interacts and Stabilizes HIF-2α via Binding to the HIF-2α bHLH and PAS Domains.	HIF1A EPAS1	1.12e-05	2	117	2	31189709
Pubmed	Neural regulation of hypoxia-inducible factors and redox state drives the pathogenesis of hypertension in a rodent model of sleep apnea.	HIF1A EPAS1	1.12e-05	2	117	2	25953833
Pubmed	HIF1α is necessary for exercise-induced neuroprotection while HIF2α is needed for dopaminergic neuron survival in the substantia nigra pars compacta.	HIF1A EPAS1	1.12e-05	2	117	2	25796140
Pubmed	Impact of HIF-1alpha and HIF-2alpha on proliferation and migration of human pulmonary artery fibroblasts in hypoxia.	HIF1A EPAS1	1.12e-05	2	117	2	16263938
Pubmed	The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.	HIF1A EPAS1	1.12e-05	2	117	2	16826581
Pubmed	Cancer stem cells and hypoxia-inducible factors (Review).	HIF1A EPAS1	1.12e-05	2	117	2	29845228
Pubmed	2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.	HIF1A EPAS1	1.12e-05	2	117	2	25218350
Pubmed	Distinct roles for the hypoxia-inducible transcription factors HIF-1α and HIF-2α in human osteoclast formation and function.	HIF1A EPAS1	1.12e-05	2	117	2	33273561
Pubmed	Hypoxia-inducible factor pathway activation in restless legs syndrome patients.	HIF1A EPAS1	1.12e-05	2	117	2	21985026
Pubmed	Clinicopathological and prognostic significance of HIF-1α and HIF-2α expression in small cell lung cancer.	HIF1A EPAS1	1.12e-05	2	117	2	23375698
Pubmed	The MRTF-A/B function as oncogenes in pancreatic cancer.	MRTFB MRTFA	1.12e-05	2	117	2	26498848
Pubmed	Epidermal deletion of HIF-2α stimulates wound closure.	HIF1A EPAS1	1.12e-05	2	117	2	24037341
Pubmed	Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1alpha) and HIF-2alpha in stem cells.	HIF1A EPAS1	1.12e-05	2	117	2	16611993
Pubmed	Primary endothelial cell-specific regulation of hypoxia-inducible factor (HIF)-1 and HIF-2 and their target gene expression profiles during hypoxia.	HIF1A EPAS1	1.12e-05	2	117	2	30917010
Pubmed	Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation.	HIF1A EPAS1	1.12e-05	2	117	2	14645546
Pubmed	Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.	MRTFB MRTFA	1.12e-05	2	117	2	12944485
Pubmed	Targeting hypoxia-inducible factors with 32-134D safely and effectively treats diabetic eye disease in mice.	HIF1A EPAS1	1.12e-05	2	117	2	37227777
Pubmed	Hypoxia-inducible factors 1alpha and 2alpha exert both distinct and overlapping functions in long bone development.	HIF1A EPAS1	1.12e-05	2	117	2	19899108
Pubmed	Hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha are expressed in kaposi sarcoma and modulated by insulin-like growth factor-I.	HIF1A EPAS1	1.12e-05	2	117	2	16899596
Interaction	CD40 interactions	TNPO1 SGK1 RIPK2 ORC4 COG1 COG6 LTN1 MLST8	2.56e-06	153	114	8	int:CD40
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	USP17L4 USP17L2 USP17L1 USP17L3 CSMD1 USP17L8	3.21e-05	234	117	6	chr8p23
Cytoband	8p23.1	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	4.93e-05	154	117	5	8p23.1
GeneFamily	Components of oligomeric golgi complex	COG1 COG6	5.19e-04	8	79	2	493
Coexpression	LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB	HIF1A RBMS1 ZMYND8 MED13L ZNF385D MTUS1 UGGT2 CACNA2D3	8.90e-07	169	116	8	M39230
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	PMS1 HIF1A RBMS1 ZMYND8 NCK1 ZMIZ1 MED13L ADARB1 TIAM1 PTPRK ATXN2 SIPA1L1 LTN1 HLTF AQR MRTFA	1.20e-06	856	116	16	M4500
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	TNPO1 PMS1 USP17L4 USP17L2 TTC41P USP17L1 NRDC SGK1 KTI12 ERI2 TRIM5 SLC5A6 SIPA1L1 NUP210 USP17L3 ATM USP17L8	4.97e-06	1072	116	17	MM1031
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	PMS1 RBMS1 ZMYND8 NCK1 ZMIZ1 MED13L ADARB1 TIAM1 PTPRK ATXN2 LIMCH1	7.33e-06	466	116	11	M13522
Coexpression	TRAVAGLINI_LUNG_EREG_DENDRITIC_CELL	HIF1A RAP2A SEM1 SGK1 RBMS1 RIPK2 ZMIZ1 CDCP1 SIPA1L1 TLR2 MAFB EPAS1	9.94e-06	577	116	12	M41697
Coexpression	MADAN_DPPA4_TARGETS	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	4.07e-05	86	116	5	MM1312
CoexpressionAtlas	kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_500	SGK1 DDX60 DYSF ADARB1 TRIM5 CEACAM1 SMPDL3A HECW2 FGD5 LIMCH1 EPAS1	7.67e-06	417	106	11	gudmap_kidney_adult_RenMedVasc_Tie2_500
CoexpressionAtlas	kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_1000	SGK1 RBMS1 DDX60 DYSF ADARB1 TRIM5 CEACAM1 MRTFB MTUS1 SMPDL3A HECW2 LTN1 FGD5 LIMCH1 EPAS1	2.08e-05	850	106	15	gudmap_kidney_adult_RenMedVasc_Tie2_1000
ToppCell	droplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CEACAM1 SMPDL3A TKT TLN1 MAFB FMNL1 ADSS1	3.40e-07	170	117	7	4d28dc9eb572f43809619f923978cd7494853d43
ToppCell	droplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CEACAM1 SMPDL3A TKT TLN1 MAFB FMNL1 ADSS1	3.53e-07	171	117	7	ed5886d6aa87b2d73469d39dc217227bd4d4c918
ToppCell	droplet-Heart-4Chambers-18m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGK1 DYSF ADARB1 CEACAM1 FGD5 CNGB1 EPAS1	4.63e-07	178	117	7	ba2f0585626988b511046630bc16be5c5fec3fb2
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MYH13 MED13L TLN1 TLR2 MAFB CSMD1 CDH11	6.23e-07	186	117	7	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SGK1 RBMS1 DYSF CEACAM1 HECW2 FGD5 EPAS1	7.98e-07	193	117	7	456aa8a8f1f9cbba0bd618a5f623909079c0f56b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SGK1 DYSF ADARB1 CEACAM1 HECW2 FGD5 EPAS1	9.16e-07	197	117	7	cd509e49bbdbf991cc5913960ff3ef275ad40628
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SGK1 DYSF ADARB1 CEACAM1 HECW2 FGD5 EPAS1	9.16e-07	197	117	7	412cb5f37df57121ddd1492021445479c7cbccbf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SGK1 DYSF CEACAM1 HECW2 FGD5 LIMCH1 EPAS1	9.47e-07	198	117	7	07701c73137947ed4a27e225975329235bbb8734
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SGK1 DYSF CEACAM1 HECW2 FGD5 LIMCH1 EPAS1	9.47e-07	198	117	7	31ba87552be97c9b78c9e82f98e96699ccb19824
ToppCell	3'-Pediatric_IBD-SmallIntestine-Endothelial\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DYSF ZNF385D MRTFB MTUS1 FGD5 LIMCH1 EPAS1	9.47e-07	198	117	7	13203249e5743ba2699871c184d141207e550a86
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SGK1 DYSF CEACAM1 HECW2 FGD5 LIMCH1 EPAS1	9.47e-07	198	117	7	fa84bf8533d1b91d2c2bcf06b710670605072b89
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SGK1 RBMS1 DYSF TIAM1 HECW2 LIMCH1 EPAS1	9.80e-07	199	117	7	5d976d57872a8a25a11fe8cd53b01aa21a1a519a
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SGK1 DYSF CEACAM1 HECW2 FGD5 LIMCH1 EPAS1	9.80e-07	199	117	7	8b62d43af8b2ebb4c1b2d068d50beaf35728dbe7
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SGK1 DYSF CEACAM1 HECW2 FGD5 LIMCH1 EPAS1	9.80e-07	199	117	7	da5a88749d859d535daa030d0974485906cc0ba7
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SGK1 DYSF CEACAM1 HECW2 FGD5 LIMCH1 EPAS1	1.01e-06	200	117	7	ced14d83222dbebca85c40540e76824e683354f3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DYSF CCER1 HECW2 UHRF1 FGD5 EPAS1	3.46e-06	155	117	6	5d157478669b609e1f0f0a75afd0112571fc2c46
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SGK1 RIPK2 ANKRD34B TLR2 MAFB CACNA2D3	6.30e-06	172	117	6	c32e6af9e2d29da47b5d870207b598cff11aef6c
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SGK1 RIPK2 ANKRD34B TLR2 MAFB CACNA2D3	6.30e-06	172	117	6	1a0556c97fcba126126c22adea5235d977d41ebe
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DYSF CEACAM1 ZNF385D HECW2 FGD5 EPAS1	6.30e-06	172	117	6	c056d44e2e130ceccadfcdceb192a7f095d779c8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SGK1 DYSF CEACAM1 HECW2 FGD5 EPAS1	6.51e-06	173	117	6	afa6bb19df52541d8d17cbfac9cbdd18a5f3632d
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RAP2A ADARB1 FREM1 LIMCH1 CDH11 EPAS1	6.95e-06	175	117	6	282f09bbdfa70d93b3f66591dcfb84c5ee0268c7
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SGK1 DYSF CEACAM1 HECW2 FGD5 EPAS1	7.18e-06	176	117	6	dc5a22f9d1347f157bdd93e6e5769b983deccf1a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SGK1 RBMS1 DYSF HECW2 FGD5 EPAS1	7.18e-06	176	117	6	64e426f5e84884ce2c29acf6f4b958962a63927f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DYSF CEACAM1 HECW2 FGD5 LIMCH1 EPAS1	7.91e-06	179	117	6	8f9e538c822940785130297712b75131812a4603
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	TACC2 ZNF385B BMP1 PTPRK MTUS1 LIMCH1	8.17e-06	180	117	6	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TACC2 ZNF385B BMP1 PTPRK MTUS1 LIMCH1	8.97e-06	183	117	6	6847c1252d6bb105524f812658112517fd351eab
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	TACC2 ZNF385B BMP1 PTPRK MTUS1 LIMCH1	8.97e-06	183	117	6	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	IPF-Epithelial-ATII\|World / Disease state, Lineage and Cell class	TACC2 ZNF385B BMP1 PTPRK MTUS1 LIMCH1	9.84e-06	186	117	6	6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TACC2 ZNF385B CDCP1 MTUS1 LIMCH1 CACNA2D3	9.84e-06	186	117	6	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	Control-Epithelial-ATII\|World / Disease state, Lineage and Cell class	TACC2 ZNF385B BMP1 PTPRK MTUS1 LIMCH1	9.84e-06	186	117	6	f4b6e401e19a71beddc73d8a1e08359f7c4025cf
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SGK1 ZMYND8 CEACAM1 PRKD3 ATM ZMAT1	1.01e-05	187	117	6	0099def970fbc828756fbf853eca2ce77b8cd342
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DDX60 DYSF MRTFB HECW2 FGD5 EPAS1	1.01e-05	187	117	6	f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1
ToppCell	facs-Heart-LV-18m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGK1 DYSF CEACAM1 FGD5 LIMCH1 EPAS1	1.05e-05	188	117	6	ed11e26ff4ef3d6314b5f5734062519b9aa285c1
ToppCell	facs-Heart-LV-18m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGK1 DYSF CEACAM1 FGD5 LIMCH1 EPAS1	1.05e-05	188	117	6	e5a8ca4613ab0bf1584b9e78959adf41d0bf379f
ToppCell	COPD-Epithelial-ATII\|COPD / Disease state, Lineage and Cell class	TACC2 ZNF385B BMP1 PTPRK MTUS1 LIMCH1	1.05e-05	188	117	6	eb6d79d733b53f64ca615bb777c64ed456866549
ToppCell	facs-Heart-LV-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGK1 DYSF CEACAM1 FGD5 LIMCH1 EPAS1	1.05e-05	188	117	6	0fc3a6562e6895f6fe7a93397eae842a75c60c93
ToppCell	3'-Adult-Distal_Rectal-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RBMS1 ZNF385D MTUS1 FGD5 LIMCH1 EPAS1	1.08e-05	189	117	6	0c612ff5f882f2d8ec744a347780bbbe7cc471bd
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	RAP2A ADARB1 FREM1 UGGT2 LIMCH1 CDH11	1.08e-05	189	117	6	dc5164591dea45b420798b94dda211be03daa70c
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADARB1 FREM1 TIAM1 SMPDL3A LIMCH1 CDH11	1.08e-05	189	117	6	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RBMS1 ZNF385D MTUS1 FGD5 LIMCH1 EPAS1	1.08e-05	189	117	6	bc8949bd4f425ed36e2c05e653c94cb1593c5bee
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DYSF CEACAM1 ZNF385D TIAM1 FGD5 EPAS1	1.11e-05	190	117	6	656483751e4bf137e4e4bfb2a03a478a8f7fcb63
ToppCell	Control-Epithelial-ATII\|Control / Disease state, Lineage and Cell class	TACC2 ZNF385B BMP1 PTPRK MTUS1 LIMCH1	1.11e-05	190	117	6	d50902a3abcc18aafa36d83cc2c6e07d7f7cb197
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	RAP2A ADARB1 FREM1 UGGT2 LIMCH1 CDH11	1.11e-05	190	117	6	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DYSF CEACAM1 ZNF385D HECW2 FGD5 EPAS1	1.14e-05	191	117	6	f663131a4810584c5854bd64ee7991a237b7707f
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	RAP2A ADARB1 FREM1 UGGT2 LIMCH1 CDH11	1.14e-05	191	117	6	3379d145d34f89150f7b06d1340022cfc6b4a6ce
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TACC2 ZNF385B BMP1 PTPRK MTUS1 LIMCH1	1.14e-05	191	117	6	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TACC2 ZNF385B BMP1 PTPRK MTUS1 LIMCH1	1.14e-05	191	117	6	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	droplet-Pancreas-PANCREAS-30m-Endothelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGK1 DYSF CEACAM1 HECW2 FGD5 EPAS1	1.18e-05	192	117	6	f4cd65e6c5b17bcabf45fe5b687246c72e7975f7
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)\|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PRUNE2 ABCA13 AZU1 CEACAM1 ZNF385D UHRF1	1.18e-05	192	117	6	072281344d58e85c9a290750b488d0c101f75d54
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DDX60 DYSF MRTFB HECW2 FGD5 EPAS1	1.18e-05	192	117	6	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	TACC2 ZNF385B BMP1 PTPRK MTUS1 LIMCH1	1.18e-05	192	117	6	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGK1 DYSF CEACAM1 HECW2 FGD5 EPAS1	1.18e-05	192	117	6	bcd8876235be503186f119653b39476488c0fa15
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TACC2 ZNF385B BMP1 PTPRK MTUS1 LIMCH1	1.21e-05	193	117	6	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ZNF385D PTPRK SMPDL3A HECW2 LIMCH1 CDH11	1.21e-05	193	117	6	9f69edc97b868d23998abc98928a2e89a885ef8a
ToppCell	3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DYSF MTUS1 MAFB FGD5 LIMCH1 EPAS1	1.21e-05	193	117	6	0f2967afbbf4e538b63f985c0acc2e5d9aab7589
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TACC2 ZNF385B BMP1 PTPRK MTUS1 LIMCH1	1.21e-05	193	117	6	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SGK1 DYSF CEACAM1 HECW2 FGD5 EPAS1	1.21e-05	193	117	6	52e918884877b6659cdca0496390e440f73694a9
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DYSF CEACAM1 HECW2 FGD5 LIMCH1 EPAS1	1.25e-05	194	117	6	74a9fdb73f279bebb6337510deab9aaaf9f7e957
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DYSF MRTFB PTPRK HECW2 FGD5 EPAS1	1.25e-05	194	117	6	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TACC2 ZNF385B BMP1 PTPRK MTUS1 LIMCH1	1.25e-05	194	117	6	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DYSF CEACAM1 ZNF385D HECW2 FGD5 EPAS1	1.25e-05	194	117	6	ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SGK1 DYSF CEACAM1 HECW2 FGD5 EPAS1	1.25e-05	194	117	6	e55dc30e200c9f576804acb642175eb4fa9146b5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SGK1 DYSF CEACAM1 HECW2 FGD5 EPAS1	1.29e-05	195	117	6	23ced69fd904f1d4114b1a7f99f4b5f65ea8824b
ToppCell	facs-Aorta-Heart-3m-Endothelial\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGK1 DYSF HECW2 FGD5 LIMCH1 EPAS1	1.29e-05	195	117	6	8493f2f60fc356af28b9c0e287d4cd8c8899c081
ToppCell	facs-Aorta-Heart-3m-Endothelial-aortic_endothelial_cell\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGK1 DYSF HECW2 FGD5 LIMCH1 EPAS1	1.29e-05	195	117	6	5e5ca7bd94c9e924ed76f7ccac199be745d4c4eb
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DYSF ADARB1 CEACAM1 HECW2 FGD5 EPAS1	1.33e-05	196	117	6	8ad8efb631164b46f0c082572270188e5ead20bf
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SGK1 DYSF CEACAM1 HECW2 FGD5 EPAS1	1.33e-05	196	117	6	023312af38f816a44b407e0daa32590d953caf99
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SGK1 DYSF CEACAM1 HECW2 FGD5 EPAS1	1.33e-05	196	117	6	65d882c6e7f6d5778b8a5fd4fdaf012e1b9f6100
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DYSF CEACAM1 HECW2 FGD5 LIMCH1 EPAS1	1.33e-05	196	117	6	ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DYSF CEACAM1 HECW2 FGD5 LIMCH1 EPAS1	1.33e-05	196	117	6	22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DYSF CEACAM1 ZNF385D HECW2 FGD5 EPAS1	1.33e-05	196	117	6	8f2031b1a9232c389517fbf3c29f47f9468b0077
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DYSF CEACAM1 ZNF385D HECW2 FGD5 EPAS1	1.33e-05	196	117	6	48b4a9cea97a55190217deaf51bf867608c5a9a7
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SGK1 FREM1 ZNF385D TIAM1 MTUS1 MAFB	1.33e-05	196	117	6	7af6c5147ac859353504d19727dbe24f63a29dd4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DYSF ADARB1 CEACAM1 HECW2 FGD5 EPAS1	1.33e-05	196	117	6	9606ea7e42f707e69ea891b3521037613b9675f5
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DYSF CEACAM1 ZNF385D HECW2 FGD5 EPAS1	1.33e-05	196	117	6	473980c827443464d08a0be28c53e3536369b12a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DYSF CEACAM1 HECW2 FGD5 LIMCH1 EPAS1	1.33e-05	196	117	6	adee900dcd16dbaba15c58bdcace09ba20214950
ToppCell	COVID-19-lung-Capillary_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DYSF MRTFB PTPRK HECW2 FGD5 EPAS1	1.33e-05	196	117	6	ac28e9be288af6f00a841aea4ce4b99aed6b4505
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SGK1 MED13L ADARB1 MRTFB LIMCH1 EPAS1	1.36e-05	197	117	6	66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb
ToppCell	severe_COVID-19-Classical_Monocyte\|World / disease group, cell group and cell class (v2)	HIF1A SGK1 DYSF TKT TLR2 MAFB	1.36e-05	197	117	6	cdffd49db7374d223ded46d636cd4be12d464ea4
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	DYSF MRTFB PTPRK HECW2 FGD5 EPAS1	1.36e-05	197	117	6	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	BL\|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	HIF1A NRDC DYSF TLN1 TLR2 FMNL1	1.36e-05	197	117	6	1acf0191fa0a25cd20bfd9ea7bf727a1555986a1
ToppCell	nucseq-Immune-Immune_Myeloid-IM\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	HIF1A SGK1 SMPDL3A SIPA1L1 TLR2 MAFB	1.36e-05	197	117	6	6f41c8f815851968849428ec92c16745bd01a3fb
ToppCell	nucseq-Immune-Immune_Myeloid-IM-IM\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	HIF1A SGK1 SMPDL3A SIPA1L1 TLR2 MAFB	1.36e-05	197	117	6	304044ace926943b8eb588f686ecbe5d1689a809
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SGK1 RBMS1 DYSF HECW2 FGD5 EPAS1	1.40e-05	198	117	6	92416e65a0dc1a4bf931833407620ea05d362f56
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	HIF1A SGK1 MED13L TLN1 MAFB FMNL1	1.40e-05	198	117	6	61ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCell	3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DYSF ZNF385D MRTFB FGD5 LIMCH1 EPAS1	1.40e-05	198	117	6	5b86dc00acf8ac2ede008f5d79c09996485bf250
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TACC2 ZNF385B BMP1 PTPRK MTUS1 TLR2	1.40e-05	198	117	6	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DYSF MRTFB HECW2 FGD5 LIMCH1 EPAS1	1.40e-05	198	117	6	e9e98c20ff7b3f3851db86381550ce7085e2db9e
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TACC2 ZNF385B BMP1 PTPRK MTUS1 TLR2	1.40e-05	198	117	6	2e2a4e1756bba6f4fbe529559a97d2993c890b4b
ToppCell	IPF-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	HIF1A TACC2 ERI2 ZNF385D MRTFB FBXO31	1.40e-05	198	117	6	b8bd1ba268480f54451648e01631b615a3401144
ToppCell	ILEUM-non-inflamed-(7)_ACKR1+_endothelial_cells\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ZNF385D MRTFB MTUS1 FGD5 LIMCH1 EPAS1	1.40e-05	198	117	6	f8a6a75c9f2fbe32a22b14b6a029411c73c09f68
ToppCell	COVID-19_Mild-Classical_Monocyte\|COVID-19_Mild / Disease condition and Cell class	HIF1A SGK1 DYSF TKT TLR2 MAFB	1.40e-05	198	117	6	30ada3de865b6fb2b14196a1cbfd4740c6a57ce3
ToppCell	COPD-Myeloid-Macrophage\|Myeloid / Disease state, Lineage and Cell class	HIF1A SGK1 SIPA1L1 TLR2 MAFB CSMD1	1.44e-05	199	117	6	1cf1b2d6debf9e3389f1829dcaa2857e9533a080
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TACC2 ZNF385B BMP1 PTPRK MTUS1 LIMCH1	1.44e-05	199	117	6	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	10x5'v1-week_14-16-Myeloid_neutrophil-granulo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HIF1A ABCA13 DYSF CEACAM1 TKT FMNL1	1.44e-05	199	117	6	5919933c4b842b98fc98685dc8c72c8dd32c6ea3
ToppCell	COPD-Myeloid-Macrophage\|COPD / Disease state, Lineage and Cell class	HIF1A SGK1 ZMIZ1 SIPA1L1 TLR2 MAFB	1.44e-05	199	117	6	4b9c53fb4f44190d2f6ad4d52b13be01ebe4955e
ToppCell	IPF-Myeloid-Macrophage\|Myeloid / Disease state, Lineage and Cell class	HIF1A SGK1 SMPDL3A SIPA1L1 TLR2 MAFB	1.44e-05	199	117	6	3c2b362d5e824e1a04830e70352f8818de984174
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	DYSF ZNF385D MTUS1 FGD5 LIMCH1 EPAS1	1.44e-05	199	117	6	97052c28e354833901f28d339b09f97f50a5b752
ToppCell	5'-Adult-LargeIntestine-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DYSF ZNF385D MRTFB MTUS1 LIMCH1 EPAS1	1.44e-05	199	117	6	ffebd99d55d31cf51b4878b2690ed0b9b3799223
ToppCell	10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HIF1A ABCA13 DYSF CEACAM1 TKT FMNL1	1.44e-05	199	117	6	caf2e050b21e7a16ce4e51b3f135debd06810231
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	RBMS1 KIAA0586 TACC2 ZMIZ1 MED13L YEATS2 MRTFB TIAM1 ATXN2 SIPA1L1	1.18e-08	171	111	10	7535_DN
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	9.94e-07	46	115	5	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.59e-06	69	115	5	DOID:1682 (implicated_via_orthology)
Disease	uterine fibroid	RBMS1 DNAH2 EBF2 COG6 ATM CSMD1 MRTFA	1.35e-05	199	115	7	EFO_0000731
Disease	response to cisplatin, platinum measurement	SEM1 DYSF ADARB1 CSMD1	5.53e-05	53	115	4	EFO_0010154, GO_0072718
Disease	Amphetamine-Related Disorders	CUBN ZNF385D CSMD1 MAP2K5	2.15e-04	75	115	4	C0236733
Disease	Amphetamine Abuse	CUBN ZNF385D CSMD1 MAP2K5	2.15e-04	75	115	4	C0236807
Disease	Amphetamine Addiction	CUBN ZNF385D CSMD1 MAP2K5	2.15e-04	75	115	4	C0236804
Disease	DNA methylation	DNHD1 ABCA13 TRIM5 FREM1 ZBTB49 TIAM1 STIP1 CSMD1 CDH11 CACNA2D3	2.53e-04	656	115	10	GO_0006306
Disease	psoriasis (is_marker_for)	HIF1A TLR2 EPAS1	6.80e-04	44	115	3	DOID:8893 (is_marker_for)
Disease	QRS complex, QRS duration	TKT SIPA1L1 EPAS1	7.26e-04	45	115	3	EFO_0005054, EFO_0005055
Disease	platelet component distribution width	PRUNE2 MYH13 ZMYND8 NCK1 ZMIZ1 CUBN ATXN2 TLN1 MAFB EPAS1	7.56e-04	755	115	10	EFO_0007984
Disease	urate measurement	UBQLN4 ZMIZ1 CUBN DYSF ORC4 ATXN2 TKT UHRF1 UGGT2 STIP1 EPAS1	7.62e-04	895	115	11	EFO_0004531
Disease	bronchopulmonary dysplasia (biomarker_via_orthology)	HIF1A EPAS1	9.69e-04	12	115	2	DOID:11650 (biomarker_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH13 DYSF	9.69e-04	12	115	2	DOID:11720 (implicated_via_orthology)
Disease	R-6-hydroxywarfarin measurement	DDX60 DNAH2 MAFB AQR	1.05e-03	114	115	4	EFO_0803327
Disease	Drug habituation	CDCP1 ZNF385D LIMCH1 CSMD1	1.09e-03	115	115	4	C0013170
Disease	Drug abuse	CDCP1 ZNF385D LIMCH1 CSMD1	1.09e-03	115	115	4	C0013146
Disease	Prescription Drug Abuse	CDCP1 ZNF385D LIMCH1 CSMD1	1.09e-03	115	115	4	C4316881
Disease	Substance-Related Disorders	CDCP1 ZNF385D LIMCH1 CSMD1	1.09e-03	115	115	4	C0236969
Disease	Drug Use Disorders	CDCP1 ZNF385D LIMCH1 CSMD1	1.09e-03	115	115	4	C0013222
Disease	Drug Dependence	CDCP1 ZNF385D LIMCH1 CSMD1	1.09e-03	115	115	4	C1510472
Disease	Substance Dependence	CDCP1 ZNF385D LIMCH1 CSMD1	1.09e-03	115	115	4	C0038580
Disease	Substance Use Disorders	CDCP1 ZNF385D LIMCH1 CSMD1	1.09e-03	115	115	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	CDCP1 ZNF385D LIMCH1 CSMD1	1.09e-03	115	115	4	C0029231
Disease	Substance abuse problem	CDCP1 ZNF385D LIMCH1 CSMD1	1.12e-03	116	115	4	C0740858
Disease	neuroblastoma	MYH13 ZNF385B TRIM5 CSMD1	1.12e-03	116	115	4	EFO_0000621
Disease	testosterone measurement	ZAN NRDC UBQLN4 DNAH2 ZNF385B ZMIZ1 PTPN21 CWC22 EBF2 MACO1 MAFB MYO15A EPAS1	1.41e-03	1275	115	13	EFO_0004908
Disease	celiac disease	ZMIZ1 PTPRK ATXN2 MTTP	1.52e-03	126	115	4	EFO_0001060
Disease	mannan-binding lectin serine protease 1 measurement	ZNF385B CWC22	1.53e-03	15	115	2	EFO_0008223
Disease	cholesteatoma of middle ear (is_marker_for)	HIF1A TLR2	1.74e-03	16	115	2	DOID:10964 (is_marker_for)
Disease	monocyte count	TNPO1 AZU1 NCK1 ZMIZ1 MED13L ATXN2 TKT TLN1 MAFB STIP1 ATM POTEA MRTFA	1.92e-03	1320	115	13	EFO_0005091
Disease	serum alanine aminotransferase measurement	TNPO1 STRA8 DNAH2 NCK1 TRIM5 ATXN2 NUP210 LTN1 MTTP MAFB	2.15e-03	869	115	10	EFO_0004735
Disease	mean platelet volume	TNPO1 ARGFX ZAN NRDC ZMYND8 ZMIZ1 CWC22 TRIM5 ATXN2 STIP1 MRTFA	2.16e-03	1020	115	11	EFO_0004584
Disease	Feeding difficulties	ZMIZ1 SLC5A6	2.21e-03	18	115	2	C0232466
Disease	response to methotrexate, juvenile idiopathic arthritis	ZMIZ1 CSMD1	2.47e-03	19	115	2	EFO_0002609, GO_0031427
Disease	kidney failure (biomarker_via_orthology)	HIF1A TLR2	2.47e-03	19	115	2	DOID:1074 (biomarker_via_orthology)
Disease	polycystic kidney disease (biomarker_via_orthology)	HIF1A EPAS1	2.47e-03	19	115	2	DOID:0080322 (biomarker_via_orthology)
Disease	emphysema imaging measurement	TIAM1 PTPRK LIMCH1 CSMD1	2.60e-03	146	115	4	EFO_0007626
Disease	unipolar depression	MYH13 NRDC ABCA13 RBMS1 ZMYND8 ADARB1 EBF2 ZNF385D SERPINB13 TKT CSMD1 CACNA2D3	2.64e-03	1206	115	12	EFO_0003761
Disease	response to alcohol	ZNF385D SIPA1L1 CNGB1	3.18e-03	75	115	3	EFO_0005526
Disease	peak expiratory flow	TNPO1 NRDC RBMS1 DYSF PTPRK MRTFA CACNA2D3	3.43e-03	498	115	7	EFO_0009718
Disease	response to clopidogrel, cardiovascular event measurement	DYSF FREM1	3.61e-03	23	115	2	EFO_0006919, GO_1903493
Disease	Antihypertensive use measurement	SEM1 EBF2 ATXN2 TKT FGD5	3.87e-03	265	115	5	EFO_0009927
Disease	non-melanoma skin carcinoma	ZAN DNAH2 BPIFA3 HERC2 MYO15A	3.87e-03	265	115	5	EFO_0009260

Protein segments in the cluster

Peptide	Gene	Start	Entry
PNFNAMDPIQKAVIN	ZNF385D	51	Q9H6B1
QLQSPTLNSPIYMQK	ERI2	341	A8K979
LSANVPNDKFTQNPM	EPAS1	756	Q99814
QASFENPMYDTNLKP	CSMD1	3531	Q96PZ7
IYNDNINTEMPRQPK	CDCP1	706	Q9H5V8
INRNYSNMKVIPPQD	ARGFX	16	A6NJG6
QPIAYEGQNKNPEMC	EBF2	136	Q9HAK2
NITNQMDFLYPNPIS	ABCA13	2686	Q86UQ4
SQIQQLNQMPLYPTE	AQR	416	O60306
VELAQQVLYMQPPTQ	DNHD1	4246	Q96M86
NLKSPLRDQYNMCPD	C7orf31	466	Q8N865
IQPGQEYNFLKMEPQ	BMP1	241	P13497
PKVPQESLFMAQDFN	CCER1	391	Q8TC90
ADPNMIYQVETNPIN	CPXCR1	36	Q8N123
VRQMNYAAQPDKDDP	RAP2A	161	P10114
QMAKQQEQDPTNLYI	RBMS1	131	P29558
ALKYMVSNPNENSLN	KIAA1107	576	Q9UPP5
NEACQENKDLQPYMP	LEMD3	681	Q9Y2U8
YKLMPELPQYDQDNL	LTN1	1406	O94822
MVKYLLENNADPNIQ	ANKRD34B	66	A5PLL1
NPQMRYTLSPENLQS	HECW2	16	Q9P2P5
LDNTQIMNALQKYPN	ORC4	406	O43929
MPSDQYELQLQNSIP	NUP210	276	Q8TEM1
PQSLNVGKPLYQSMN	FBXO42	626	Q6P3S6
DYLNTPQMNTPVTLN	MED13L	1011	Q71F56
NYQQMNPEALNLTPE	MAFB	91	Q9Y5Q3
LVPKNYVTVMQNNPL	NCK1	241	P16333
ISYTKMHPNNENLPQ	KTI12	326	Q96EK9
ANLKNPQIMYLEQEL	MTUS1	1126	Q9ULD2
LPLDINNYPMAKFVQ	MYO15A	2041	Q9UKN7
KLPAQVPMEYNHLQE	HERC2	4326	O95714
YNDVMLPSPNEKLQN	HIF1A	431	Q16665
PNIMTLNKTDPANQF	SMPDL3A	216	Q92484
YGPLTMSLKPQQQQQ	ATXN2	156	Q99700
YNPEDVLNVFKMDPN	CWC22	376	Q9HCG8
IPPKMNQFLYNLKEN	BPIFA3	181	Q9BQP9
LADMNQEYQLPLSKI	DDX60	1546	Q8IY21
RMYDLNSNNPNPIIS	MLST8	66	Q9BVC4
EFYMQLLQQALPPEQ	MACO1	191	Q8N5G2
APSPQAFDEMLKNIQ	FBXO31	521	Q5XUX0
YPQIQKNQGSLMPLQ	MAP2K5	356	Q13163
IILNNNPSYMDVKNI	MTTP	546	P55157
NIPAMNSDYENIQIP	FGD5	776	Q6ZNL6
KDLSDMQIAYQPPNS	FREM1	361	Q5H8C1
KNEPQMDSNYARLLQ	MRTFB	306	Q9ULH7
PQMQLNLAPYTLNFL	HERVK_113	771	P63132
DINDQIQNAAFMYPP	PRKD3	781	O94806
IGKYENSQNNLPQIM	LCA5L	186	O95447
NALMQLNEIKPGLQY	ADARB1	81	P78563
NENPYPNPSLQKEMA	DPRX	36	A6NFQ7
QLQAQDYPSPNIMRT	PTPN21	546	Q16825
NLKECYLMENPQEPD	PLA2G4E	761	Q3MJ16
VMNPINEYKDPENIL	COG6	631	Q9Y2V7
IISPNYPKQYDNNMN	CUBN	2931	O60494
FNLPQVQKVMPNDTF	GAL3ST2	121	Q9H3Q3
TMNPLKALYLQQRPE	ATM	2961	Q13315
QDPSQFDVLVMPNLY	IDH3A	241	P50213
PQQPSQEKFYSMAAQ	COG1	106	Q8WTW3
DVQVPTNMYNKDPAI	CACNA2D3	171	Q8IZS8
QSDPIMLNVNYNALP	CEACAM1	406	P13688
SQIDNNEPYMKIPCN	EIF3I	131	Q13347
EEQKLESNNPYKPQS	CENPJ	76	Q9HC77
VNDNPPKFPQSVYQM	CDH11	261	P55287
SQLLEMLNDSQYNPK	DDX24	486	Q9GZR7
MNLPPDKVQLLSQYD	FMNL1	46	O95466
KLSLYLQQNFEPMQA	CCDC196	216	A0A1B0GTZ2
EMVALQRDPNNPYDK	HLTF	81	Q14527
GYDPQQNLNDLMLLQ	AZU1	106	P20160
QNVQEYLDPTLNPML	DNAH2	3441	Q9P225
PNSQYQMLLDPTNPS	ZMYND8	371	Q9ULU4
ANIYMVPQNIKPALQ	DYSF	1316	O75923
CKVSNNNYPIPEQMN	PMS1	526	P54277
NNYPIPEQMNLNEDS	PMS1	531	P54277
PQNYLEGMMLQEQLP	CPHXL	321	A0A1W2PPM1
DPNEKNTFMNNIPDF	PTCHD3	711	Q3KNS1
NDPNPMKYLRQQSLP	LIMCH1	481	Q9UPQ0
LRNSKPNMVEAPEQY	PTPRK	1411	Q15262
LLQNMQNQDPSIPYA	OR1E2	81	P47887
QLLSDYKENQMPNNS	POTEA	281	Q6S8J7
LLQNMQNQDPSIPYA	OR1E1	81	P30953
IPYFPANQEMLQKVE	ADSS1	386	Q8N142
QDKNEESLPFQNLPM	PRUNE2	731	Q8WUY3
NPFNMPNLYQKLESD	STIP1	126	P31948
EYPMSIQQAQAAPDQ	SLC5A6	321	Q9Y289
NTAEMYDNILNKPLQ	SGK1	301	O00141
VSTMLPYTPNNKQQL	SIPA1L1	686	O43166
PAFAKQQINLEMPNS	SEM1	51	Q6ZVN7
PGYEEAMSQQPKQQE	MRTFA	726	Q969V6
QVPDPPDNMNLAKNF	SPICE1	511	Q8N0Z3
NPENPEEKFQLYMQI	STRA8	276	Q7Z7C7
MNQTDKNQQEIPSYL	TMEM263	1	Q8WUH6
KYQFPQSIDPLTNLM	CNGB1	641	Q14028
PDAMCNIEKNENYQP	TRIM5	381	Q9C035
LAKNVQYPECLDMQP	USP17L3	291	A6NCW0
LAKNVQYPECLDMQP	USP17L4	291	A6NCW7
FLIENKMQLYVPQPE	TIAM1	811	Q13009
KQQQPNPVEQRYMEL	MTM1	546	Q13496
DPAPLQHQMDIYQKR	TKT	191	P29401
PYKNNDLSMFVLLPN	SERPINB13	236	Q9UIV8
LLENPVQPINDMSYF	TLN1	1376	Q9Y490
KQPFEDVTNPLQIMY	RIPK2	226	O43353
NLLDNNPRDQATMKY	TTC41P	936	Q6P2S7
TLNNDQVFPMNPPKF	MYH13	71	Q9UKX3
LNFKPLEQEMPVQFQ	NRDC	881	O43847
MQESPKLPQQSYNFD	TACC2	2356	O95359
LAKNVQYPECLDMQP	USP17L1	291	Q7RTZ2
LFPNFNTMDPVQKAV	ZNF385B	126	Q569K4
AMLNNAQPDQYEAPD	TNPO1	631	Q92973
QVVMLNYNPDNPKER	UHRF1	221	Q96T88
DSLPQPYRMINKLVN	WDR93	51	Q6P2C0
LAKNVQYPECLDMQP	USP17L8	291	P0C7I0
KLAKPQMQQTQPQAY	ZBTB49	676	Q6ZSB9
PNNMIYQVAIKSLPQ	UGGT2	1431	Q9NYU1
ENLMVQELENFNPPF	TLR2	656	O60603
SENPQLMQNVISAPY	UBQLN4	391	Q9NRR5
NQYDLFKNNGLPLMI	TERB1	331	Q8NA31
LAKNVQYPECLDMQP	USP17L2	291	Q6R6M4
YMQPPVTNTQSLDQQ	KIAA0586	1346	Q9BVV6
NNPYVIMDKQPGQVI	YEATS2	496	Q9ULM3
LQETQNKDINQYGPM	ZMIZ1	306	Q9ULJ6
AAPYNISQAMEKQLP	ZMAT1	281	Q5H9K5
NNQKMAVPYRPNEHL	ZAN	2411	Q9Y493